Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Episurf Medical B | EPISB | Nov 21, 2024 | 0.15 | -1.18 |
EQL Pharma | EQL | Nov 21, 2024 | 66.40 | +3.75 |
EQT | EQT | Nov 21, 2024 | 299.40 | +1.70 |
Ericsson A | ERICA | Nov 21, 2024 | 87.60 | -0.34 |
Ericsson B | ERICB | Nov 21, 2024 | 87.96 | +0.11 |
ES Energy Save Holding | ESGRB | Nov 21, 2024 | 29.05 | +0.17 |
Essity A | ESSITYA | Nov 21, 2024 | 298.50 | +0.51 |
Essity B | ESSITYB | Nov 21, 2024 | 298.90 | +0.30 |
Eurobattery Minerals | BAT | Nov 21, 2024 | 0.11 | -6.78 |
European Institute of Science B | EURIB | Nov 21, 2024 | 2.30 | +8.49 |
Everysport Group AB | EVERY | Nov 21, 2024 | 17.40 | +0.29 |
Evolear AB | EVOL | Nov 21, 2024 | 0.50 | -28.57 |
Evolution | EVO | Nov 21, 2024 | 977.00 | -0.37 |
Ework Group AB. | EWRK | Nov 21, 2024 | 139.40 | -0.14 |
Exalt | EXALT | Nov 21, 2024 | 0.42 | 0.00 |
ExpreS2ion Biotech Holding | EXPRS2 | Nov 21, 2024 | 19.90 | -5.01 |
Exsitec | EXS | Nov 21, 2024 | 144.00 | 0.00 |
Eyeonid Group | EOID | Nov 21, 2024 | 17.24 | -4.22 |
Fabege | FABG | Nov 21, 2024 | 81.10 | -1.34 |
Fable Media Group AB | FABLE | Nov 21, 2024 | 6.90 | -1.43 |
Fagerhult Group AB | FAG | Nov 21, 2024 | 58.60 | +0.69 |
Fantasma Games | FAGA | Nov 21, 2024 | 57.50 | 0.00 |
Fasadgruppen | FG | Nov 21, 2024 | 40.85 | +0.37 |
Fastator | FASTAT | Nov 21, 2024 | 1.17 | -2.33 |
Fastout Int | FOUT | Nov 21, 2024 | 0.15 | 0.00 |
Fastpartner A | FPARA | Nov 21, 2024 | 65.00 | -1.52 |
Fastpartner D | FPARD | Nov 21, 2024 | 70.90 | -1.25 |
Fenix Outdoor B | FOIB | Nov 21, 2024 | 597.00 | -0.33 |
Ferroamp AB | FERRO | Nov 21, 2024 | 3.80 | -3.55 |
Ferronordic | FNM | Nov 21, 2024 | 61.10 | -1.45 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.